In Brief: Benzoyl peroxide proposal
This article was originally published in The Rose Sheet
Executive Summary
Benzoyl peroxide proposal: FDA extending comment period 60 days for a Feb. 17 proposed rule establishing additional labeling for all topical acne products containing benzoyl peroxide ("The Rose Sheet" Feb. 20, p. 12) to July 17, according to a May 19 Federal Register notice. FDA granted the extension after receiving a request from the Nonprescription Drug Manufacturers Association, which stated that it needed more time due to the "precedent-breaking nature of the agency's proposal," the notice says...